February 28, 2020 / 1:38 AM / a month ago

BRIEF-Prescient Therapeutics Says HY Revenues From Ordinary Activities Down 3.6% To $42,016

Feb 28 (Reuters) - Prescient Therapeutics Ltd:

* HY REVENUES FROM ORDINARY ACTIVITIES DOWN 3.6% TO $42,016

* HY LOSS AFTER INCOME TAX ATTRIBUTABLE $1.7 MILLION VERSUS LOSS OF $1.6 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below